The diversity of receptor recognition in cholesterol-dependent cytolysins

Microbiology and Immunology

Volumn 58, Issue 3, 2014, Pages 155-171

  Tabata, Atsushi ^a   Ohkura, Kazuto ^b   Ohkubo, Yukimasa ^a   Tomoyasu, Toshifumi ^a   Ohkuni, Hisashi ^c   Whiley, Robert A ^d   Nagamune, Hideaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Health Sciences Research Institute East Japan Company Limited   (Japan)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cholesterol dependent cytolysins; Receptor recognition; Streptococcus mitis derived human platelet aggregation factor; Vaginolysin

Indexed keywords

BACTERIAL PROTEIN; CD59 ANTIGEN; CHOLESTEROL; CHOLESTEROL DEPENDENT CYTOLYSIN; CYTOLYSIN; INTERMEDILYSIN; LECTINOLYSIN; MITILYSIN; STREPTOCOCCUS MITIS DERIVED HUMAN PLATELET AGGREGATION FACTOR; SUILYSIN; UNCLASSIFIED DRUG; VAGINOLYSIN;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CHANNEL GATING; GARDNERELLA VAGINALIS; HUMAN; HUMAN CELL; MICROBIAL DIVERSITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; RECEPTOR AFFINITY; RECEPTOR RECOGNITION; STREPTOCOCCUS MITIS;

CHOLESTEROL-DEPENDENT CYTOLYSINS; RECEPTOR RECOGNITION; STREPTOCOCCUS MITIS-DERIVED HUMAN PLATELET AGGREGATION FACTOR; VAGINOLYSIN;

BACTERIAL TOXINS; CELL MEMBRANE; CHOLESTEROL; CYTOTOXINS; HUMANS; KINETICS; PROTEIN BINDING; RECEPTORS, CELL SURFACE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS INTERMEDIUS; STREPTOCOCCUS MITIS;

EID: 84895562361     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12131     Document Type: Article

References (52)

1. Limbago B., Penumalli V., Weinrick B., Scott J.R. (2000) Role of streptolysin O in a mouse model of invasive group A streptococcal disease. Infect Immun 68: 6384-90.
2. Timmer A.M., Timmer J.C., Pence M.A., Hsu L.C., Ghochani M., Frey T.G., Karin M., Salvesen G.S., Nizet V. (2009) Streptolysin O promotes group A Streptococcus immune evasion by accelerated macrophage apoptosis. J Biol Chem 284: 862-71.
3. Sakurai A., Maruyama F., Funao J., Nozawa T., Aikawa C., Okahashi N., Shintani S., Hamada S., Ooshima T., Nakagawa I. (2010) Specific behavior of intracellular Streptococcus pyogenes that has undergone autophagic degradation is associated with bacterial streptolysin O and host small G proteins Rab5 and Rab7. J Biol Chem 285: 22666-75.
4. Harder J., Franchi L., Muñoz-Planillo R., Park J.H., Reimer T., Núñez G.J. (2009) Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappa B activation but proceeds independently of TLR signaling and P2X7 receptor. J Immunol 183: 5823-9.
5. Stassen M., Müller C., Richter C., Neudörfl C., Hültner L., Bhakdi S., Walev I., Schmitt E. (2003) The streptococcal exotoxin streptolysin O activates mast cells to produce tumor necrosis factor alpha by p38 mitogen-activated protein kinase- and protein kinase C-dependent pathways. Infect Immun 71: 6171-7.
6. García-Suárez Mdel M., Cima-Cabal M.D., Flórez N., García P., Cernuda-Cernuda R., Astudillo A., Vázquez F., De los Toyos J.R., Méndez F.J. (2004) Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin. Infect Immun 72: 4534-40.
7. McNeela E.A., Burke A., Neill D.R., Baxter C., Fernandes V.E., Ferreira D., Smeaton S., El-Rachkidy R., McLoughlin R.M., Mori A., Moran B., Fitzgerald K.A., Tschopp J., Pétrilli V., Andrew P.W., Kadioglu A., Lavelle E.C. (2010) Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 6: e1001191. doi:10.1371/journal.ppat.1001191.
8. Shin H.S., Yoo I.H., Kim Y.J., Kim H.B., Jin S., Ha U.H. (2010) MKP1 regulates the induction of inflammatory response by pneumococcal pneumolysin in human epithelial cells. FEMS Immunol Med Microbiol 60: 171-8.
9. Yoo I.H., Shin H.S., Kim Y.J., Kim H.B., Jin S., Ha U.H. (2010) Role of pneumococcal pneumolysin in the induction of an inflammatory response in human epithelial cells. FEMS Immunol Med Microbiol 60: 28-35.
10. Littmann M., Albiger B., Frentzen A., Normark S., Henriques-Normark B., Plant L. (2009) Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression. EMBO Mol Med 1: 211-22.
11. Dessing M.C., Hirst R.A., de Vos A.F., van der Poll T. (2009) Role of Toll-like receptors 2 and 4 in pulmonary inflammation and injury induced by pneumolysin in mice. PLoS ONE 4: e7993. doi:10.1371/journal.pone.0007993.
12. Shoma S., Tsuchiya K., Kawamura I., Nomura T., Hara H., Uchiyama R., Daim S., Mitsuyama M. (2008) Critical involvement of pneumolysin in production of interleukin-1alpha and caspase-1-dependent cytokines in infection with Streptococcus pneumoniae in vitro: a novel function of pneumolysin in caspase-1 activation. Infect Immun 76: 1547-57.
13. Marriott H.M., Mitchell T.J., Dockrell D.H. (2008) Pneumolysin: a double-edged sword during the host-pathogen interaction. Curr Mol Med 8: 497-509.
14. O'Brien D.K., Melville S.B. (2004) Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues. Infect Immun 72: 5204-15.
15. Glomski I.J., Gedde M.M., Tsang A.W., Swanson J.A., Portnoy D.A. (2002) The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells. J Cell Biol 156: 1029-38.
16. Vadia S., Arnett E., Haghighat A.C., Wilson-Kubalek E.M., Tweten R.K., Seveau S. (2011) The pore-forming toxin listeriolysin O mediates a novel entry pathway of L. monocytogenes into human hepatocytes. PLoS Pathog 7: e1002356. doi:10.1371/journal.ppat.1002356.
17. Dewamitta S.R., Nomura T., Kawamura I., Hara H., Tsuchiya K., Kurenuma T., Shen Y., Daim S., Yamamoto T., Qu H., Sakai S., Xu Y., Mitsuyama M. (2010) Listeriolysin O-dependent bacterial entry into the cytoplasm is required for calpain activation and interleukin-1 alpha secretion in macrophages infected with Listeria monocytogenes. Infect Immun 78: 1884-94.
18. Tsuchiya K., Kawamura I., Takahashi A., Nomura T., Kohda C., Mitsuyama M.(2005) Listeriolysin O-induced membrane permeation mediates persistent interleukin-6 production in Caco-2 cells during Listeria monocytogenes infection in vitro. Infect Immun 73: 3869-77.
19. Nomura T., Kawamura I., Tsuchiya K., Kohda C., Baba H., Ito Y., Kimoto T., Watanabe I., Mitsuyama M. (2002) Essential role of interleukin-12 (IL-12) and IL-18 for gamma interferon production induced by listeriolysin O in mouse spleen cells. Infect Immun 70: 1049-55.
20. Kayal S., Lilienbaum A., Poyart C., Memet S., Israel A., Berche P. (1999) Listeriolysin O-dependent activation of endothelial cells during infection with Listeria monocytogenes: activation of NF-kappa B and upregulation of adhesion molecules and chemokines. Mol Microbiol 31: 1709-22.
21. Hamon M.A., Ribet D., Stavru F., Cossart P. (2012) Listeriolysin O: the Swiss army knife of Listeria. Trends Microbiol 20: 360-8.
22. Nagamune H., Ohkura K., Sukeno A., Cowan G., Mitchell T.J., Ito W., Ohnishi O., Hattori K., Yamato M., Hirota K., Miyake Y., Maeda T., Kourai H. (2004) The human-specific action of intermedilysin, a homolog of streptolysin O, is dictated by domain 4 of the protein. Microbiol Immunol 48: 677-92.
23. Hotze E.M., Tweten R.K.(2012) Membrane assembly of the cholesterol-dependent cytolysin pore complex. Biochim Biophys Acta 1818: 1028-38.
24. Ramachandran R., Tweten R.K., Johnson A.E. (2004) Membrane-dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and intersubunit β-strand alignment. Nat Struct Mol Biol 11: 697-705.
25. Mitchell T.J. (2003) The pathogenesis of streptococcal infections: from tooth decay to meningitis. Nat Rev Microbiol 1: 219-30.
26. Balachandran P., Hollingshead S.K., Paton J.C., Briles D.E. (2001) The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin. J Bacteriol 183: 3108-16.
27. Price K.E., Greene N.G., Camilli A. (2012) Export requirements of pneumolysin in Streptococcus pneumoniae. J Bacteriol 194: 3651-60.
28. Jefferies J., Nieminen L., Kirkham L.A., Johnston C., Smith A., Mitchell T.J. (2007) Identification of a secreted cholesterol-dependent cytolysin (mitilysin) from Streptococcus mitis. J Bacteriol 189: 627-32.
29. Farrand S., Hotze E., Friese P., Hollingshead S.K., Smith D.F., Cummings R.D., Dale G.L., Tweten R.K. (2008) Characterization of a streptococcal cholesterol-dependent cytolysin with a Lewis y and b specific lectin domain. Biochemistry 47: 7097-107.
30. Giddings K.S., Zhao J., Sims P.J., Tweten R.K. (2004) Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat Struct Mol Biol 11: 1173-8.
31. Wickham S.E., Hotze E.M., Farrand A.J., Polekhina G., Nero T.L., Tomlinson S., Parker M.W., Tweten R.K. (2011) Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8α and C9. J Biol Chem 286: 20952-62.
32. Gelber S.E., Aguilar J.L., Lewis K.L., Ratner A.J. (2008) Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis. J Bacteriol 190: 3896-903.
33. Ohkuni H., Todome Y., Okibayashi F., Watanabe Y., Ohtani N., Ishikawa T., Asano G., Kotani S. (1997) Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65. FEMS Immunol Med Microbiol 17: 121-9.
34. Ohkuni H., Nagamune H., Ozaki N., Tabata A., Todome Y., Watanabe Y., Takahashi H., Ohkura K., Kourai H., Ohtsuka H., Fischetti V.A., Zabriskie J.B. (2012) Characterization of recombinant Streptococcus mitis-derived human platelet aggregation factor. APMIS 120: 56-71.
35. Nagamune H., Ohnishi C., Katsuura A., Fushitani K., Whiley R.A., Tsuji A., Matsuda Y. (1996) Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infect Immun 64: 3093-100.
36. Bavdek A., Gekara N.O., Priselac D., Gutirrez Aguirre I., Darji A., Chakraborty T., Macek P., Lakey J.H., Weiss S., Anderluh G. (2007) Sterol and pH interdependence in the binding, oligomerization, and pore formation of Listeriolysin O. Biochemistry 46: 4425-37.
37. Hatanaka M., Seya T., Matsumoto M., Hara T., Nonaka M., Inoue N., Takeda J., Shimizu A. (1996) Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines. Biochem J 314: 969-76.
38. Perrière G., Gouy M. (1996) WWW-Query: an on-line retrieval system for biological sequence banks. Biochimie 78: 364-9.
39. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-8.
40. Shimada Y., Maruya M., Iwashita S., Ohno-Iwashita Y. (2002) The C-terminal domain of perfringolysin O is an essential cholesterol-binding unit targeting to cholesterol-rich microdomains. Eur J Biochem 269: 6195-203.
41. Farrand A.J., LaChapelle S., Hotze E.M., Johnson A.E., Tweten R.K. (2010) Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc Natl Acad Sci USA 107: 4341-6.
42. Ramachandran R., Heuck A.P., Tweten R.K., Johnson A.E. (2002) Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. Nat Struct Mol Biol 9: 823-7.
43. Soltani C.E., Hotze E.M., Johnson A.E., Tweten R.K. (2007) Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin. J Biol Chem 282: 15709-16.
44. Soltani C.E., Hotze E.M., Johnson A.E., Tweten R.K. (2007) Structural elements of the cholesterol-dependent cytolysins that are responsible for their cholesterol-sensitive membrane interactions. Proc Natl Acad Sci USA 104: 20226-31.
45. Kimberley F.C., Sivasankar B., Paul Morgan B. (2007) Alternative roles for CD59. Mol Immunol 44: 73-81.
46. Nagamune H., Ohkura K., Umezu K., Shouji H., Kourai H. (2004) A cell membrane modification technique using domain 4 of intermedilysin for immunotherapy against cancer. Anticancer Res 24: 3367-72.
47. Polekhina G., Giddings K.S., Tweten R.K., Parker M.W. (2005) Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin. Proc Natl Acad Sci USA 102: 600-5.
48. Ohkura K., Hori H., Nagamune H. (2006) Molecular dynamics of human-specific cytolysin: analysis of membrane binding motif for therapeutic application. Anticancer Res 26: 4055-62.
49. Hughes T.R., Ross K.S., Cowan G.J., Sivasankar B., Harris C.L., Mitchell T.J., Morgan B.P. (2009) Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59. Mol Immunol 46: 1561-7.
50. LaChapelle S., Tweten R.K., Hotze E.M. (2009) Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis. J Biol Chem 284: 12719-26.
51. Dowd K.J., Tweten R.K. (2012) The cholesterol-dependent cytolysin signature motif: a critical element in the allosteric pathway that couples membrane binding to pore assembly. PLoS Pathog 8: e1002787. doi: 10.1371/journal.ppat.1002787.
52. Johnson S., Brooks N.J., Smith R.A., Lea S.M., Bubeck D. (2013) Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59. Cell Rep 3: 1369-77.